KRYS vs SRE · P/E 46, rev $235.6M vs P/E 31, rev $13.70B
Krystal Biotech Inc (KRYS) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the KRYS and SRE stock pages for the full models.
Not investment advice.